Search
for
Sort by
Research 811–840 of 1000+
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Pharmacotherapy of alopecia areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Cutaneous side-effects of EGFR inhibitors and their management.
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Ornithine Decarboxylase Expression Leads to Translocation and Activation of Protein Kinase CK2 in Vivo
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?
- Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells
- Mycophenolate Antagonizes IFN-γ-Induced Catagen-Like Changes via β-Catenin Activation in Human Dermal Papilla Cells and Hair Follicles
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors